---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-25-000064"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2025-10-07T23:59:59+00:00"
generated_at: "2026-05-17T04:23:36.029108+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# PetMed Express to restate FY2024, FY2023; investigation reveals revenue errors, former CEO/CFO out

## Summary
- Net sales overstated by ~$7.0M in FY2024 and ~$9.0M in FY2023 due to vendor payment misclassification; no net income impact.
- Investigation found Dec and Mar accelerated shipments: $133k and $1.1M revenue in wrong periods; $50 coupon and nepotism issues.
- Former CEO Sandra Campos, former CFO Robyn D'Elia, former Audit Chair Diana Purcel resigned; Board adopted remediation plan.
- Company expects to file FY2025 10-K by mid-October 2025; material weaknesses in internal controls to be reported.
- Also recorded $1.2M non-cash impairment of PCRX trade name; possible additional goodwill impairment due to stock decline.

## SEC filing metadata
- accession: 0001040130-25-000064
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2025-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- confidence: high
- sec_items: 2.06, 4.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000064/0001040130-25-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000064/pets-20251001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-25-000064
- JSON: https://secwatch.observer/filing/0001040130-25-000064.json
- Plain text: https://secwatch.observer/filing/0001040130-25-000064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.